Report Detail
Global Subcutaneous Immunoglobulins Market Growth 2019-2024
- RnM3002040 |
- 22 February, 2019 |
- Global |
- 131 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Subcutaneous Immunoglobulin (SCIg) infusions are administered by slowly injecting purified immunoglobulin into fatty tissue underneath the skin. SCIg can be administered at home by patients or carers, using an infusion pump (spring loaded or battery powered) or by rapid push (a manual method that does not require a pump).
The classification of subcutaneous immunoglobulins includes 10% purity and 20% purity, and in U.S. the proportion of 10% purity in 2016 is about 70%, and the proportion is in decreasing trend from 2012 to 2016.
Market competition is intense. In United States, only Shire (Baxalta), Grifols, CSL products got the approval of FDA. They are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Subcutaneous Immunoglobulins market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Subcutaneous Immunoglobulins business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Immunoglobulins market by product type, application, key manufacturers and key regions and countries.
This study considers the Subcutaneous Immunoglobulins value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
10% Purity
20% Purity
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Primary Immunodeficiency
Secondary Immunodeficiency
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Shire (Baxalta)
Grifols
CSL
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Subcutaneous Immunoglobulins consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Subcutaneous Immunoglobulins market by identifying its various subsegments.
Focuses on the key global Subcutaneous Immunoglobulins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Subcutaneous Immunoglobulins with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Subcutaneous Immunoglobulins submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Subcutaneous Immunoglobulins Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Subcutaneous Immunoglobulins Consumption 2014-2024
- 2.1.2 Subcutaneous Immunoglobulins Consumption CAGR by Region
- 2.2 Subcutaneous Immunoglobulins Segment by Type
- 2.2.1 10% Purity
- 2.2.2 20% Purity
- 2.3 Subcutaneous Immunoglobulins Consumption by Type
- 2.3.1 Global Subcutaneous Immunoglobulins Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Subcutaneous Immunoglobulins Sale Price by Type (2014-2019)
- 2.4 Subcutaneous Immunoglobulins Segment by Application
- 2.4.1 Primary Immunodeficiency
- 2.4.2 Secondary Immunodeficiency
- 2.4.3 Others
- 2.5 Subcutaneous Immunoglobulins Consumption by Application
- 2.5.1 Global Subcutaneous Immunoglobulins Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Subcutaneous Immunoglobulins Value and Market Share by Application (2014-2019)
- 2.5.3 Global Subcutaneous Immunoglobulins Sale Price by Application (2014-2019)
3 Global Subcutaneous Immunoglobulins by Players
- 3.1 Global Subcutaneous Immunoglobulins Sales Market Share by Players
- 3.1.1 Global Subcutaneous Immunoglobulins Sales by Players (2017-2019)
- 3.1.2 Global Subcutaneous Immunoglobulins Sales Market Share by Players (2017-2019)
- 3.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Players
- 3.2.1 Global Subcutaneous Immunoglobulins Revenue by Players (2017-2019)
- 3.2.2 Global Subcutaneous Immunoglobulins Revenue Market Share by Players (2017-2019)
- 3.3 Global Subcutaneous Immunoglobulins Sale Price by Players
- 3.4 Global Subcutaneous Immunoglobulins Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Subcutaneous Immunoglobulins Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Subcutaneous Immunoglobulins Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Subcutaneous Immunoglobulins by Regions
- 4.1 Subcutaneous Immunoglobulins by Regions
- 4.1.1 Global Subcutaneous Immunoglobulins Consumption by Regions
- 4.1.2 Global Subcutaneous Immunoglobulins Value by Regions
- 4.2 Americas Subcutaneous Immunoglobulins Consumption Growth
- 4.3 APAC Subcutaneous Immunoglobulins Consumption Growth
- 4.4 Europe Subcutaneous Immunoglobulins Consumption Growth
- 4.5 Middle East & Africa Subcutaneous Immunoglobulins Consumption Growth
5 Americas
- 5.1 Americas Subcutaneous Immunoglobulins Consumption by Countries
- 5.1.1 Americas Subcutaneous Immunoglobulins Consumption by Countries (2014-2019)
- 5.1.2 Americas Subcutaneous Immunoglobulins Value by Countries (2014-2019)
- 5.2 Americas Subcutaneous Immunoglobulins Consumption by Type
- 5.3 Americas Subcutaneous Immunoglobulins Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Subcutaneous Immunoglobulins Consumption by Countries
- 6.1.1 APAC Subcutaneous Immunoglobulins Consumption by Countries (2014-2019)
- 6.1.2 APAC Subcutaneous Immunoglobulins Value by Countries (2014-2019)
- 6.2 APAC Subcutaneous Immunoglobulins Consumption by Type
- 6.3 APAC Subcutaneous Immunoglobulins Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Subcutaneous Immunoglobulins by Countries
- 7.1.1 Europe Subcutaneous Immunoglobulins Consumption by Countries (2014-2019)
- 7.1.2 Europe Subcutaneous Immunoglobulins Value by Countries (2014-2019)
- 7.2 Europe Subcutaneous Immunoglobulins Consumption by Type
- 7.3 Europe Subcutaneous Immunoglobulins Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Subcutaneous Immunoglobulins by Countries
- 8.1.1 Middle East & Africa Subcutaneous Immunoglobulins Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Subcutaneous Immunoglobulins Value by Countries (2014-2019)
- 8.2 Middle East & Africa Subcutaneous Immunoglobulins Consumption by Type
- 8.3 Middle East & Africa Subcutaneous Immunoglobulins Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Subcutaneous Immunoglobulins Distributors
- 10.3 Subcutaneous Immunoglobulins Customer
11 Global Subcutaneous Immunoglobulins Market Forecast
- 11.1 Global Subcutaneous Immunoglobulins Consumption Forecast (2019-2024)
- 11.2 Global Subcutaneous Immunoglobulins Forecast by Regions
- 11.2.1 Global Subcutaneous Immunoglobulins Forecast by Regions (2019-2024)
- 11.2.2 Global Subcutaneous Immunoglobulins Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Subcutaneous Immunoglobulins Forecast by Type
- 11.8 Global Subcutaneous Immunoglobulins Forecast by Application
12 Key Players Analysis
- 12.1 Shire (Baxalta)
- 12.1.1 Company Details
- 12.1.2 Subcutaneous Immunoglobulins Product Offered
- 12.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Shire (Baxalta) News
- 12.2 Grifols
- 12.2.1 Company Details
- 12.2.2 Subcutaneous Immunoglobulins Product Offered
- 12.2.3 Grifols Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Grifols News
- 12.3 CSL
- 12.3.1 Company Details
- 12.3.2 Subcutaneous Immunoglobulins Product Offered
- 12.3.3 CSL Subcutaneous Immunoglobulins Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 CSL News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Subcutaneous Immunoglobulins . Industry analysis & Market Report on Subcutaneous Immunoglobulins is a syndicated market report, published as Global Subcutaneous Immunoglobulins Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Subcutaneous Immunoglobulins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
